Private equity company, Abry Partners has announced it will acquire a majority stake in Centauri Health Solutions, a provider of healthcare technology and services.
Abry joins Silversmith Capital Partners, which financed Centauri with a $50 million growth investment in 2016, as well as SV Health Investors. Though, the financial terms agreed upon between Abry and Centauri were not disclosed. This news arrives off the back of the private equity firm investing in London-based Options Technology, which offers cloud applications to financial services firms.
The Scottsdale, Arizona-based provider of technology-enabled revenue optimization and quality of care services to health plans, health care providers, hospitals, and health systems have focused on improving the lives and health outcomes of patients since its inception in 2014.
As Centauri is added to Abry’s ever-growing portfolio of healthcare investments, it looks to enjoy new growth across product development, sales, marketing and its own strategic acquisitions.
“When we invested in Centauri, the company had fewer than 100 employees, and [has] now closed 2019 with over 1,200 employees,” said Managing Partner of Silversmith, Jim Quagliaroli.
"Centauri represents an ideal investment for Abry within one of our core industry verticals,” said Nick Scola, Partner at Abry in a statement. Founder and CEO “Adam [Miller] and his team have built an exceptional company that delivers tangible economic value to payers, providers and patients within an increasingly complex and competitive healthcare environment. We truly look forward to working with the Centauri leadership team to drive growth through continued investment in technology and people, as well as strategic M&A."
The transaction is expected to be finalized in Q1. Upon closing, Nick Scola, Chris Ritchie and Joe Cammarosano of Abry will join Jim Quagliaroli of Silversmith, Michael Balmuth of SV Health, and CEO Adam Miller on Centauri's Board of Directors.
In December, Centauri Health announced that it had met the requirements by the National Committee for Quality Assurance (NCQA) for Healthcare Effectiveness Data and Information Set (HEDIS) 2020 certification for hybrid measures, systematic sampling and survey sample, making it the company’s 15th consecutive year to meet this milestone. The NCQA certification is widely understood to be a seal of quality for consumers and employers.